Stereotactic radiosurgery for brain metastases: A case-matched study comparing treatment results for patients 80 years of age or older versus patients 65-79 years of age

Journal of Neurosurgery

Volumn 121, Issue 5, 2014, Pages 1148-1157

  Watanabe, Shinya ^a,b   Yamamoto, Masaaki ^a,c   Sato, Yasunori ^d   Kawabe, Takuya ^a,e   Higuchi, Yoshinori ^f   Kasuya, Hidetoshi ^c   Yamamoto, Tetsuya ^b   Matsumura, Akira ^b   Barfod, Bierta E ^a  

^a HITACHI LTD   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d Clinical Research Center   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain metastases; Elderly cases; Gamma Knife; Oncology; Radiation therapy; Stereotactic radiosurgery

Indexed keywords

AGE; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DETERIORATION; FEMALE; GAMMA KNIFE; GAMMA KNIFE RADIOSURGERY; HEALTH STATUS; HUMAN; INCIDENCE; INSTITUTIONAL REVIEW; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; METASTASIS RESECTION; NEUROLOGICAL COMPLICATION; NEUROTOXICITY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPENSITY SCORE; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; STEREOTACTIC RADIOSURGERY; SURGICAL MORTALITY; SURGICAL PATIENT; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY; AGING; BRAIN NEOPLASMS; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; NEUROSURGERY; PHYSIOLOGY; PROCEDURES; RADIOSURGERY; SECONDARY; SURVIVAL;

AGED; AGED, 80 AND OVER; AGING; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NEUROSURGICAL PROCEDURES; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL; TREATMENT OUTCOME;

EID: 84922393882     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2014.6.JNS132790     Document Type: Article

References (35)

1. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483-2491, 2006
2. Bakoyannis G, Touloumi G: Practical methods for competing risks data: a review. Stat Methods Med Res 21:257-272, 2012
3. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
4. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751, 1997
5. Gooley TA, Leisenring W, Crowley J, Storer BE: Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695-706, 1999
6. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
7. Hanssens P, Karlsson B, Yeo TT, Chou N, Beute G: Detection of brain micrometastases by high-resolution stereotactic magnetic resonance imaging and its impact on the timing of and risk for distant recurrences. Clinical article. J Neurosurg 115:499-504, 2011
8. Hayashi M, Yamamoto M, Nishimura C, Satoh H: Do recent advances in MR technologies contribute to better gamma knife radiosurgery treatment results for brain metastases? Neuroradiol J 20:481-490, 2007
9. Hotta T, Kohno H, Taniguchi E, Magaki T, Hidaka T, Nishimoto T: Treatment option for elderly patients with metastatic brain tumors. Jpn J Cancer Clin 45:1143-1148, 1999
10. Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD: T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 66:486-492, 2010
11. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
12. Karnofsky DA, Buechenal JH: The clinical evaluation of chemotherapeutic agents in cancer, in MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949, pp 191-205
13. Kim SH, Weil RJ, Chao ST, Toms SA, Angelov L, Vogelbaum MA, et al: Stereotactic radiosurgical treatment of brain metastases in older patients. Cancer 113:834-840, 2008
14. Lorenzoni J, Devriendt D, Massager N, David P, Ruíz S, Vanderlinden B, et al: Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 60:218-224, 2004
15. Lutterbach J, Bartelt S, Momm F, Becker G, Frommhold H, Ostertag C: Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases. Cancer 103:1234-1244, 2005
16. Matsuo M, Miwa K, Shinoda J, Kako N, Nishibori H, Sakurai K, et al: Target definition by C11-methionine-PET for the radiotherapy of brain metastases. Int J Radiat Oncol Biol Phys 74:714-722, 2009
17. Minniti G, Esposito V, Clarke E, Scaringi C, Bozzao A, Lanzetta G, et al: Stereotactic radiosurgery in elderly patients with brain metastases. J Neurooncol 111:319-325, 2013
18. Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishiwata K, et al: Usefulness of L-[methyl-11C] methioninepositron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103:498-507, 2005
19. Noel G, Bollet MA, Noel S, Feuvret L, Boisserie G, Tep B, et al: Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases. Int J Radiat Oncol Biol Phys 63:1555-1561, 2005
20. Parsons LS: Reducing bias in a propensity score matchedpair sample using greedy matching techniques. SAS. (http://www2.sas.com/proceedings/sugi26/p214-26.pdf) [Accessed June 18, 2014]
21. Rades D, Pluemer A, Veninga T, Schild SE: Comparison of different treatment approaches for one to two brain metastases in elderly patients. Strahlenther Onkol 184:565-571, 2008
22. Radiation Therapy Oncology Group: Cooperative Group Common Toxicity Criteria. (http://www.rtog.org/Research Associates/AdverseEventReporting/CooperativeGroupCom monToxicityCriteria.aspx) [Accessed June 18, 2014]
23. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD: A note on competing risks in survival data analysis. Br J Cancer 91:1229-1235, 2004
24. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W: A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510-514, 2008
25. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, et al: Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655-661, 2010
26. Tsao M, Xu W, Sahgal A: A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 118:2486-2493, 2012
27. Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, et al: Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J Neurosurg 98:1056-1064, 2003
28. Weltman E, Salvajoli JV, Brandt RA, de Morais Hanriot R, Prisco FE, Cruz JC, et al: Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 46:1155-1161, 2000
29. Yamamoto M, Ide M, Nishio Si, Urakawa Y: Gamma Knife radiosurgery for numerous brain metastases: is this a safe treatment? Int J Radiat Oncol Biol Phys 53:1279-1283, 2002
30. Yamamoto M, Kawabe T, Higuchi Y, Sato Y, Barfod BE, Kasuya H, et al: Validity of three recently proposed prognostic grading indexes for breast cancer patients with radiosurgically treated brain metastases. Int J Radiat Oncol Biol Phys 84:1110-1115, 2012
31. Yamamoto M, Kawabe T, Higuchi Y, Sato Y, Nariai T, Barfod BE, et al: Delayed complications in patients surviving at least 3 years after stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 85:53-60, 2013
32. Yamamoto M, Kawabe T, Sato Y, Higuchi Y, Nariai T, Barfod BE, et al: A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ? 5 tumors. Clinical article. J Neurosurg 118:1258-1268, 2013
33. Yamamoto M, Sato Y, Serizawa T, Kawabe T, Higuchi Y, Nagano O, et al: Subclassification of recursive partitioning analysis Class II patients with brain metastases treated radiosurgically. Int J Radiat Oncol Biol Phys 83:1399-1405, 2012
34. Yamamoto M, Serizawa T, Sato Y, Kawabe T, Higuchi Y, Nagano O, et al: Validity of two recently-proposed prognostic grading indices for lung, gastro-intestinal, breast and renal cell cancer patients with radiosurgically-treated brain metastases. J Neurooncol 111:327-335, 2013
35. Yancik R, Ries LAG: Cancer in older persons: an international issue in an aging world. Semin Oncol 31:128-136, 2004